Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation

Yueh Ting Chiu, Ming Heng Tsai, Darien Zhing Herr Chan, Hui Wen Ko, Huai En Lu, Chi Ying F. Huang, Yenn Jiang Lin, Shih Lin Chang, Li Wei Lo, Ching Ying Huang, Yu Feng Hu*, Patrick C.H. Hsieh, Shih Ann Chen

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Atrial fibrillation is the most common heart disease in the world, with around 35 million patients in 2020. Here we reported the generation of IBMS-iPSC-015-06, IBMS-iPSC-016-06, and IBMS-iPSC-017-02 as human induced pluripotent stem cell (iPSC) lines from patients’ peripheral blood mononuclear cells (PBMCs) with atrial fibrillation. The cell lines expressed properties of pluripotent stem cells, including pluripotent markers and the ability to differentiate into three germ layers. These cell lines served as suitable models for studying alternative therapies of atrial fibrillation.

Original languageEnglish
Article number102419
JournalStem Cell Research
Volume54
DOIs
StatePublished - Jul 2021

Fingerprint

Dive into the research topics of 'Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation'. Together they form a unique fingerprint.

Cite this